Edgewise Therapeutics Inc (EWTX)

Cost of Revenue

$590.00K

TTM · Period ending: · USD

EWTX logo

EWTX Cost of Revenue

Latest reported$590.00K
EWTX TTM Cost of Revenue ($0.00 → $590.00K)
High-resolution chart · PNG

EWTX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Edgewise Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
590,000
590,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.